JNJ vs UBSI · P/E 17, rev $49.37B vs P/E 14, rev $834.1M
Johnson & Johnson (JNJ) versus United Bankshares Inc (UBSI) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
United Bankshares Inc (UBSI) is a banks - regional company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported UBSI revenue for 2026-06-30 was $834.1M. Net income was $255.6M. UBSI currently screens at market cap $5.46B and trailing P/E 14.2.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. UBSI currently screens at market cap $5.46B and trailing P/E 14.2.
Not investment advice. Open the JNJ and UBSI stock pages for the full models.
Not investment advice.